{"disease":{"id":"adult-onset-still-disease","name":"adult onset still disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04750863","title":"Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months of Follow-up","phase":"","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT07517250","title":"A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03651193","title":"Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Second Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT06405152","title":"Assessment of Macrophage Activation syndromE in STill's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT03276650","title":"Admission of Adult-onset Still Disease Patients in the ICU","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT02204293","title":"Canakinumab for Treatment of Adult-onset Still's Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":true},{"nct_id":"NCT03311854","title":"A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT04717635","title":"Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03265132","title":"A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT04752371","title":"A Study to Evaluate Camoteskimab in Participants With Still's Disease","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Apollo Therapeutics Ltd","has_results":false},{"nct_id":"NCT07151157","title":"Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Ruijin Hospital","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}